Submissions

Online Submissions

Already have a Username/Password for Obstetrics and Gynecology?
Go to Login

Need a Username/Password?
Go to Registration

Registration and login are required for submitting items online, and for checking the status of current submissions.

 

Author Guidelines

Instructions for Authors

1. Articles are accepted in two languages: Russian and English. An article should have a formal referral from the institution where the work was completed, and Head’s visa on the first page, certified by a round stamp. Preparing your manuscript and supporting information for submission, make sure your names, affiliations, and other identifying information do not appear in the article. The file name of the blinded manuscript must contain the first word of the article title and "for review."

1.1. The article should be printed in Times New Roman #14 with 1.5 interval, 60-62 signs in a line, 30 lines per page. Pages should be numbered. Covering papers could be scanned and sent by e-mail.

1.2. Initials and surname of the author (authors), title of the article, a full title of the institution where the paper was completed, the city and the country should be at the beginning of the first page of the manuscript. It is obligatory to specify the institution where each of authors works appear.

1.3. Each article includes an abstract. The abstract to the original article should be structured as follows: objective, subject and methods, results, conclusion. The abstract to the review article should contain a brief summary and correspond to the structure of the article. The abstract to the clinical notes includes background, description and conclusion. After the abstracts the keywords follow (while choosing keyword, MeSH keywords suggestion is recommended). Abstract and key words should be printed in italics, no indent, headings separated with paragraphs, headlines in bold type, the volume of 500-1000 characters.

1.3.1. Abstracts and annotation should be prepared in accordance with GOST R 7.0.99-2018 Abstract and annotation. General requirements. Limit your abstract to 250 words.

Immediately after the abstract, provide 10-15 keywords. The keywords should be specific and reflect the essential elements of the investigation, avoiding general and plural terms, and multiple concepts. Keywords should be written one line below the abstract and labeled as “Keywords:”.  Written on the same line and one space after the label, each keyword must be separated by a comma and space with no ending punctuation after the final keyword.

1.4. After the abstract it is necessary to submit the data on each of the authors: first name and surname; scientific degree and title; position; business address with zip code; telephone and e-mail.

1.4.1. Information about the author should include the following:

  • full first name, middle name, and family name of the author;
  • the author's institutional affiliation and its subdivision (without an indication of its organizational and legal form: FGBUN, FGBOUVO, PJSC, JSC, etc.);
  • the author's affiliation address and its subdivision in which the work was done (city and country);
  • author's e-mail address (e-mail);
  • Open Researcher and Contributor ID (ORCID) (if available).

The author can provide a full affiliation address.

The author's e-mail address should be given without the word "e-mail" and no ending punctuation mark.

ORCID identifier should be provided as an Internet address with no ending punctuation mark.

Example

Svetlana Yur'evna Barsukova1, Sergei Nikolaevich Levin2

1National Research University – Higher School of Economics, Moscow, Russia, svbars@mail.ru, https://orcid.org/0000-0002-2696-4882

2Kemerovo State University, Kemerovo, Russia, levin.sergey.n@gmail.com, https://orcid.org/0000-0003-3881-3579

One author may be designated as the corresponding author with contact details placed after all authors’ information on a separate line.

Example

Corresponding author: Ivan V. Perov, ivp@mail.ru

1.5. The volume of original articles, reviews of literature and articles of the section “Guideline for practitioners” should not exceed 12 pages, notes from practice – 5 pages. There should be not more than 3 images and/or 3 tables in the article. The editorial staff reserves the right to shorten the article.

1.6. Original articles should contain the following sections: a brief introduction, subject and methods of research, results of the research, discussion and conclusion. Authors should follow reporting guidelines that have been developed for different study designs; examples include CONSORT for randomized trials, STROBE for observational studies (checklist), PRISMA for systematic reviews and meta-analyses, STARD for studies of diagnostic accuracy, and TRIPOD for prognostic studies. A good source for reporting guidelines is the EQUATOR Network. For systematic reviews and meta-analysis – PRISMA standard.

1.7. Authors should use modern Russian scientific terminology and not use “calque” terms, transcribed from foreign words. Reduction of words and names (not more than 3) is only allowed with an initial specification of the full name, except for common abbreviations of physical and mathematical quantities. Highly specialized terms should be defined.

1.8. The article should be thoroughly verified by the author. It is necessary to clearly mark all the elements in mathematical formulas: Latin and Greek letters, superscripts and subscripts, uppercase and lowercase letters, writing of figures similar to letters.

1.9. The names of microorganisms are written in Latin and italic.

1.10. Requirements for the presentation of statistical analysis:

Statistical tests used in the study should be described in Statistical analysis subsection at the end of the Material and Methods section. Describe statistical methods with enough detail to enable a knowledgeable reader with access to the original data to judge its appropriateness for the study and to verify the reported results. Statistical methods and results should be reported according to the SAMPL Guidelines.  

2. References attached to the article should include works of national and foreign authors in the last 5-7 years. It is advisable to quote not more than 30 sources in original articles and not more than 50 – in reviews.

2.1. References should be organized by the rules of organization of references for authors based on the Uniform Requirements for Manuscripts Submitted to Biomedical Journals (see. Annex).

2.2. Bibliographic references should be enumerated; in the text they should be given in square brackets in accordance with the list.

2.3. The author takes a full responsibility for the accuracy of the list of references.

3. Tables should contain generalized and statistically processed data. Each table should have a number and a title. The units of measurements are given according to the International System of Units.

4. References to abstracts are not recognized by the international community, so they should not be given.

4. Illustrative materials (photographs, images, charts, diagrams) should be both in the text and attached in a separate file.

4.1. Images should be followed by a general title, and then all digits and letters signs should be explained. In notes to microphotographs it is necessary to indicate the method of coloring and magnification.

4.2. Images must be submitted in its original form without the use of retouching and color correction.

4.3. Images must be submitted in TIFF or JPG formats (of the highest quality).

4.4. Picture size should be at least 1500*1500 pixels.

4.5. The subject should be in focus.

5. Authorship.

5.1. The author should sign the article. A collective paper should be signed by all authors with an indication of the role of each.

Example:

  • The concept and design of the research – J. Johns, P. Peterson
  • Collection and processing of material – J. Johns
  • Statistical processing of data – J. Johns
  • Writing the text – P. Peterson
  • Editing – J. Johns

By signing the article the author thereby passes the right to publish the article to the editorial staff, guarantees its originality and certifies that neither the article nor the images have been previously published or sent for publication in other editions.

5.2. While defining the authorship, it is recommended to follow to the ICJME criteria.

6. Proofreading is not sent to the author.

7. Authors should maintain accurate records of data associated with their submitted manuscript, and to supply or provide access to these data, on reasonable request.

8. Author should not submit the same manuscript under the consideration to any other medical publication. Where portions of the content overlap with published or submitted content, to acknowledge and cite those sources. Additionally, to provide the editor with a copy of any submitted manuscript that might contain overlapping or closely related content.

9. Author should confirm that all the work in the submitted manuscript is original and to acknowledge and cite content reproduced from other sources to obtain permission to reproduce any content from other sources.

10. Authors should ensure that any studies involving human or animal subjects conform to national, local and institutional laws and requirements (e.g. WMA Declaration of HelsinkiNIH Policy on Use of laboratory AnimalsEU Directive on Use of Animals) and confirm that approval has been sought and obtained where appropriate. Authors should obtain express permission from human subjects and respect their privacy.

Patient consent for publication. All patients provided informed consent for the publication of their data (and associated images).

11.1. Acknowledgements. The authors can express their acknowledgements to the individuals and organizations that contributed to the preparation of the article.

11.2. Information about the sources of funding. It is necessary to indicate the source of funding for the research, preparing a review or a lecture (the name of the planned research work performed for the state task, the number of the grant and the name of the fund, commercial or state organization, etc.). The amount of funding is not required.

11.3. Information about the conflict of interests. Any potential conflict of interest (e.g. where the author has a competing interest (real or apparent) that could be considered or viewed as exerting an undue influence on his or her duties at any stage during the publication process) should be declared (see ICJME recommendations).

12. Authors should notify promptly the journal editor or publisher if a significant error in their publication is identified. Author should cooperate with the editor and publisher to publish an erratum, addendum, corrigendum notice, or to retract the paper, where this is deemed necessary. In identifying significant inaccuracies, errors in data, etc. after the publication editors reserve the right to withdraw the published article.

13. Authors should take full responsibility for any plagiarism of text, image or other type of graphics. Any related misconduct will be dealt in accordance with COPE algorithm.

14. When reviewing the material obtained from authors, the Editors follow the uniform requirements for manuscripts submitted to biomedical journals (Intern. Committee of Medical Journal Editors. Uniform requirements for manuscripts submitted to biomedical journals // Ann. Intern. Med. 1997; 126: 36–47), EASE principles and «Singapore Statement on Research Integrity».

15. It is recommended to authors to provide the link on their ORCID profile.

16. Authors who are invited to submit a revised version of their manuscript should carefully read reviewer comments and indicate point by point where changes have been made, highlighting them in color.

17. Authors' Data Sharing Statement. The data supporting the findings of this study are available on request from the corresponding author after approval from the principal investigator.

18. Articles with violations of the rules of registration are not considered.


Articles should be sent in electronic form:
E-mail: aig@oparina4.ru


Editors should consider retracting a publication if:

  • They have clear evidence that the findings are unreliable, either as a result of major error (eg, miscalculation or experimental error), or as a result of fabrication (eg, of data) or falsification (eg, image manipulation)
  • It constitutes plagiarism
  • The findings have previously been published elsewhere without proper attribution to previous sources or disclosure to the editor, permission to republish, or justification (ie, cases of redundant publication)
  • It contains material or data without authorisation for use
  • Copyright has been infringed or there is some other serious legal issue (eg, libel, privacy)
  • It reports unethical research
  • It has been published solely on the basis of a compromised or manipulated peer review process
  • The author(s) failed to disclose a major competing interest (a.k.a. conflict of interest) that, in the view of the editor, would have unduly affected interpretations of the work or recommendations by editors and peer reviewers.
  • COPE has produced guidance on retractions https://publicationethics.org/retraction-guidelines.

 

Submission Preparation Checklist

As part of the submission process, authors are required to check off their submission's compliance with each of the following items, and submissions that do not adhere to these guidelines may be returned to the authors.

  • Эта статья не была раньше опубликована, а также не представлена для рассмотрения и публикации в другом журнале (иначе объясните это в Примечаниях для Редактора).

  • Отправляемый файл рукописи имеет формат Microsoft Word или RTF - *.doc, *.docx, *.rtf.

  • Интернет-ссылки представлены в виде полных URL.

  • Текст набран с одинарым межстрочным интервалом, шрифт Times New Roman, 12 pt; для выделения используется курсив, а не подчеркивание (кроме интернет-ссылок); все иллюстрации, графики и таблицы расположены в тексте там, где требуется по смыслу (а не в конце документа).

  • Текст соответствует стилистическим и библиографческим требованиями Руководства для Авторов, расположенном в разделе "О нас".

  • Были удалены имена авторов из заголовка статьи и выполнены другие требования документа Обеспечение Анонимности при Рецензировании.

 

Privacy Statement

Authors and Reviewers

Manuscripts should be reviewed with due respect for authors' confidentiality. In submitting their manuscripts for review, authors entrust editors with the results of their scientific work and creative effort, on which their reputation and career may depend. Authors' rights may be violated by disclosure of the confidential details of the review of their manuscript.In addition, the editor should respect reviewer rights to confidentiality. It may need to be breached only in order to prevent fraud and deception.

Editors must not disclose information about manuscripts (including their receipt, content, status in the reviewing process, criticism by reviewers, or outcome of the reviewing process) to anyone other than the authors and reviewers. This includes requests to use the materials for legal proceedings.

Editors should notify their reviewers that manuscripts sent for review are confidential communications and the private property of the authors. Therefore, reviewers and members of the editorial staff must respect the authors' rights by not publicly discussing the authors' work before the manuscript is published. Reviewers must be prohibited from making copies of the manuscript and sharing it with any other party, except with the permission of the editor.

Reviewer comments should not be published or otherwise made public without permission of reviewer, authors and the editor. 

The Journal policy is to blind authors to reviewer identity. If reviewer comments sent to authors are not signed, the reviewer identity must not be revealed to authors or anyone else without the reviewers’ expressed written permission.

Peer reviewers’ comments should not be published without permission of the reviewer and authors. At the same time, reviewers’ comments should be sent to other persons reviewing the same manuscript, which helps reviewers learn from the review process. Reviewers also may be notified of the editor's decision to accept or reject a manuscript.

Patients and Study Participants

Patients have a right to privacy that should not be infringed without informed consent. Identifying information, including patients’ names, initials, or hospital numbers, should not be published in written descriptions, photographs, and pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication.

Informed consent for this purpose requires that a patient who is identifiable be shown the manuscript to be published. Authors should disclose to these patients whether any potential identifiable material might be available via the Internet as well as in print after publication.

Patient consent should be written and archived with the Journal, the authors, or both, as dictated by local regulations or laws. Applicable laws vary from locale to locale, and Journals should establish their own policies with legal guidance.

In order to better protect patient identity, written consent of patients can be archived by the authors. In this case, the authors should provide the Journal with a written statement that attests that they have received and archived written patient consent.

Identifying details should be omitted if they are not essential. Complete anonymity is difficult to achieve, however, and informed consent should be obtained if there is any doubt. For example, masking the eye region in photographs of patients is inadequate protection of anonymity. If identifying characteristics are altered to protect anonymity, such as in genetic pedigrees, authors should provide assurance that alterations do not distort scientific meaning and editors should so note. The requirement for informed consent should be included in the Journal’s instructions for authors. When informed consent has been obtained it should be indicated in the published article.

 

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies